Teva Pharmaceuticals Competitors and Similar CompaniesClear all
Teva Pharmaceuticals's competitors and similar companies include Pfizer, AstraZeneca and Allergan.
 Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. | ||
Founding Date | Founding Date 1901 | Founding Date 1849 | Founding Date 1999 | Founding Date 1948 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more |
Employees | Employees 37,000 | Employees 81,0008% decrease | Employees 94,300 | Employees 10,5471% decrease |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 163.9 b | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $8.3b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $8.9b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit N/A |
Net income | Net income $1.4b (FY, 2025) | Net income $7.8b (FY, 2025) | Net income $10.2b (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Countries | Countries N/A | Countries 200 (FY, 2024) | Countries 130 (FY, 2021) | Countries 100 (Q1, 2020) |
Facilities | Facilities 90 (FY, 2019) | Facilities N/A | Facilities N/A | Facilities 21 (FY, 2019) |
Funding | ||||
Total funding raised | Total funding raised $ 358m | Total funding raised N/A | Total funding raised $ 1b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyAllergan
HQ
Dublin, IE
Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.
View company